Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis

European Journal of Internal Medicine

Volumn 24, Issue 5, 2013, Pages 444-450

  Van Bommel, E F H ^a   Pelkmans, L G ^a   Van Damme, H ^a   Hendriksz, T R ^a  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Idiopathic retroperitoneal fibrosis; Outcome; Tamoxifen

Indexed keywords

ACUTE PHASE PROTEIN; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TAMOXIFEN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALLERGIC REACTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLUSHING; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC RETROPERITONEAL FIBROSIS; IMMUNOSUPPRESSIVE TREATMENT; INDIGESTION; LIBIDO DISORDER; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD DISORDER; MUSCULOSKELETAL PAIN; NAUSEA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS NEPHROSTOMY; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; REMISSION; REPEAT PROCEDURE; RETROPERITONEAL FIBROSIS; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOSIS; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; URETER OBSTRUCTION; URETER STENT; VAGINA BLEEDING; VISUAL ANALOG SCALE; VISUAL DISORDER; WEIGHT GAIN;

AGED; ESTROGEN ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROPERITONEAL FIBROSIS; TAMOXIFEN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84879079912     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.11.010     Document Type: Article

References (48)

1. A. Vaglio, C. Salvarani, and C. Buzio Retroperitoneal fibrosis Lancet 367 2006 241 251
2. E.F.H. Van Bommel, I. Jansen, T.R. Hendriksz, and A.L. Aarnoudse Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation Medicine (Baltimore) 88 2009 193 201
3. M.J. Mitchinson Retroperitoneal fibrosis revisited Arch Pathol Lab Med 10 1986 784 786
4. D.V. Parums The spectrum of chronic peri-aortitis Histopathology 16 1990 423 431
5. A.H. Kardar, S. Kattan, E. Lindstedt, and K. Hanash Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration J Urol 168 2002 550 555
6. P.M. Higgins, D.N. Bennett-Jones, P.F. Naish, and G. Aber Non-operative management of retroperitoneal fibrosis Br J Surg 75 1988 573 577
7. E.F.H. Van Bommel, C. Siemes, L.E. Hak, S.J. van der Veer, and T.R. Hendriksz Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone Am J Kidney Dis 49 2007 615 625
8. A.C. Fry, S. Singh, S.S. Gunda, G.B. Boustad, D.C. Hanbury, and T.A. McNicholas Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study Nephron Clin Pract 108 2008 213 220
9. C.P. Ilie, R.J. Pemberton, and D.A. Tolley Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment BJU Int 98 2009 137 140
10. G. Moroni, B. Gallelli, G. Banfi, S. Sandri, P. Messa, and C. Ponticelli Long-term results of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches Nephrol Dial Transplant 21 2006 2485 2490
11. M. Harreby, T. Bilde, P. Helin, H.-H. Meyhoff, H. Vinterberg, and V.-A. Nielsen Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying drugs Scand J Urol Nephrol 28 1994 237 242
12. R. Marcolongo, I.M. Tavolini, F. Laveder, M. Busa, F. Noventa, and P. Bassi Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases Am J Med 116 2004 194 197
13. K. Warnatz, A.G. Keskin, M. Uhl, C. Scholz, A. Katzenwadel, and P. Vaith Immunosuppressive treatment of chronic peri-aortitis: a retrospective study of 20 patients and a review of the literature Ann Rheum Dis 64 2005 828 833
14. S. Adler, S. Lodermeyer, J. Gaa, and U. Heemann Successful mycophenolatemofetil therapy in nine patients with idiopathic retroperitoneal fibrosis Rheumatology 47 2008 1535 1538
15. R.D. Swartz, A.M. Lake, W.W. Roberts, G.J. Faerber, and J.S. Wolf Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil Clin Nephrol 69 2008 260 268
16. P.J. Scheel, N. Feeley, and M. Sozlo Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis Ann Intern Med 154 2011 31 36
17. C.F. Clark, D. Vanderpool, and J.T. Preskitt The response of retroperitoneal fibrosis to tamoxifen Surgery 109 1991 502 506
18. R.J. Loffeld, and T.F. Van Weel Tamoxifen for retroperitoneal fibrosis Lancet 382 1993
19. R.M. Spillane, and G.J. Whitman Treatment of retroperitoneal fibrosis with tamoxifen AJR 164 1995 515 516
20. L.V. Owens, W.G. Cance, and J.F. Huth Retroperitoneal fibrosis treated with tamoxifen Am Surg 1995 515 516
21. R. Bourouma, D. Chevet, F. Michel, J.P. Cercueil, L. Arnould, and G. Rifle Treatment of idiopathic retroperitoneal fibrosis with tamoxifen Nephrol Dial Transplant 12 1997 2407 2410
22. G. Tonietto, F. Agresta, D. Della Libera, and L. Bittesini Treatment of idiopathic retroperitoneal fibrosis by tamoxifen Eur J Surg 163 1997 231 235
23. J.-M. Devevey, F. Michel, D. Chevet, G. Rifle, and L. Arnould Regression dúne fibrose retroperitoneale traitee par le tamoxifene Prog Urol 6 1996 578 581
24. L. Frankart, F. Lorge, and J. Donchier Tamoxifen for retroperitoneal fibrosis (peri-aneurysmal fibrosis) Postgrad Med J 73 1997 653 654
25. N. Al Rabi, R. Graziani, M.A. Cerruto, R. Baldassarre, V. Ficarra, and W. Artibani Clinical and radiological evolution of a case of idiopathic retroperitoneal fibrosis treated with tamoxifen Scand J Urol Nephrol 36 2002 391 392
26. P. Al-Musawi, P. Mitchenere, and M. Al-Akraa Idiopathic retroperitoneal fibrosis treated with tamoxifen only Br J Urol 82 1998 442 443
27. C. Ozener, S. Kiris, R. Lawrence, Y. Ilker, and E. Akoglu Potential beneficial effect of tamoxifen in retroperitoneal fibrosis Nephrol Dial Transplant 12 1997 2166 2168
28. J. Al-Salman, and A.R. Makhdomi Treatment of retroperitoneal fibrosis with tamoxifen South Med J 95 2002 947 [letter]
29. R. Puce, A.B. Porcaro, P. Curti, D. Girelli, M. Pantalena, and G. Mallosini Treatment of retroperitoneal fibrosis with tamoxifen: case report and review of the literature Arch Esp Urol 53 2000 184 190
30. F. Dedeoglu, C.D. Rose, B.H. Athreya, K. Conard, L. Grissom, and M. Magnusson Successful treatment of retroperitoneal fibrosis with tamoxifen in a child J Rheumatol 28 2001 1693 1695
31. A. Vaglio, A. Palmisano, F. Alberici, U. Maggioni, S. Ferretti, and R. Cobelli Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomized controlled trial Lancet 378 2011 338 346
32. M.E. Wewers, and N.K. Lowe A critical review of visual analogue scales in the measurement of clinical phenomena Res Nurs Health 13 1990 227 236
33. E.F.H. Van Bommel, T.R. Hendriksz, A.W. Huiskes, and A.G. Zeegers Brief communication: tamoxifen therapy for idiopathic retroperitoneal fibrosis Ann Intern Med 144 2006 101 106
34. A. Decensi, P. Maisonneuve, N. Rotmensz, D. Bettega, A. Costa, and V. Sachini Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial Circulation 111 2005 650 656
35. L.R. Baker Auto-allergic periaortitis (idiopathic retroperitoneal fibrosis) BJU Int 92 2003 663 665
36. L. Wei, T.M. MacDonald, and B.R. Walker Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease Ann Intern Med 141 2004 764 770
37. D.J. Grainger, and P.M. Schofield Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence Circulation 112 2005 3018 3024
38. J.R. Benson, and M. Baum Tamoxifen for retroperitoneal fibrosis Lancet 341 1993 836
39. M.A. Kuhn, X. Wang, W.G. Payne, F. Ko, and M.C. Robson Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren's affected palmar fascia J Surg Res 103 2002 146 152
40. D. Chau, J.S. Mancoll, S. Lee, J. Zao, L.G. Phillips, and G.K. Gittes Tamoxifen downregulates TGF-beta production in keloid fibroblasts Ann Plast Surg 40 1998 490 493
41. S. Garvin, and C. Dabrosin Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo Cancer Res 63 2003 8742 8748
42. D.A. McNamara, J. Harmey, J.H. Wang, E. Kay, T.N. Walsh, and D.J. Bouchier-Hayes Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo Eur J Surg Oncol 27 2001 714 718
43. R.W. McMurray Estrogen, prolactin and autoimmunity: actions and interactions Int Immunopharmacol 1 2001 995 1008
44. M. Cutolo, A. Sulli, S. Capellino, B. Villaggio, P. Montagna, and B. Seriolo Sex hormones influence on the immune system: basic and clinical aspects of autoimmunity Lupus 13 2004 635 638
45. F. Maritati, D. Corradi, A. Versari, M. Casali, M. Letizia Urban, and C. Buzio Rituximab therapy for chronic peri-aortitis Ann Rheum Dis 71 2012 1262 1264 [letter]
46. S. Costanzi, A. Zoli, P.M. Ferraro, F.M. Danza, and Ferraccioli A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen Clin Nephrol 70 2008 172 175
47. L. Pelkmans, A.L. Aarnoudse, T.R. Hendriksz, and E.F.H. van Bommel Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis Nephrol Dial Transplant 27 7 2012 2819 2825
48. M.N. Magrey, M.E. Husni, I. Kushner, and L.H. Calabrese Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 61 2009 674 679